What is the projected market valuation for the GCC non invasive-prenatal-testing market by 2035?

The projected market valuation for the GCC non invasive-prenatal-testing market is $140.0 Million by 2035. Read More

What was the overall market valuation in 2024?

The overall market valuation in 2024 was $45.5 Million. Read More

What is the expected CAGR for the GCC non invasive-prenatal-testing market during the forecast period 2025 - 2035?

The expected CAGR for the GCC non invasive-prenatal-testing market during the forecast period 2025 - 2035 is 10.76%. Read More

Which companies are considered key players in the GCC non invasive-prenatal-testing market?

Key players in the market include Illumina, Roche, Natera, Fulgent Genetics, LabCorp, Quest Diagnostics, HaploX, and Genomic Health. Read More

What are the main test types in the GCC non invasive-prenatal-testing market and their valuations?

The main test types include Cell-Free Fetal DNA Testing valued at $65.0 Million, Biochemical Markers Testing at $45.0 Million, and Ultrasound Screening at $30.0 Million. Read More

What applications are driving the GCC non invasive-prenatal-testing market?

Applications driving the market include Trisomy Detection valued at $60.0 Million, Single Gene Disorders at $45.0 Million, and Sex Chromosome Abnormalities at $35.0 Million. Read More

What technologies are utilized in the GCC non invasive-prenatal-testing market?

Technologies utilized include Next-Generation Sequencing valued at $65.0 Million, Microarray Analysis at $45.0 Million, and Massively Parallel Sequencing at $30.0 Million. Read More

Who are the primary end users of non invasive-prenatal-testing in the GCC market?

Primary end users include Diagnostic Laboratories valued at $70.0 Million, Hospitals at $46.0 Million, and Research Institutions at $24.0 Million. Read More

How does the market for Cell-Free Fetal DNA Testing compare to other test types?

Cell-Free Fetal DNA Testing leads with a valuation of $65.0 Million, surpassing Biochemical Markers Testing at $45.0 Million and Ultrasound Screening at $30.0 Million. Read More

What trends are expected to shape the GCC non invasive-prenatal-testing market in the coming years?

Trends likely to shape the market include advancements in technology and increasing demand for non invasive testing methods, contributing to the projected growth. Read More

GCC Non Invasive Prenatal Testing Market

ID: MRFR/MED/49126-HCR

200 Pages

Nidhi Mandole

Last Updated: April 06, 2026

GCC Non-Invasive Prenatal Testing Market Research Report: Size, Share, Trend Analysis By Test Type (Cell-Free DNA Testing, Biochemical Testing, Combined Screening), By Applications (Fetal Gender Determination, Chromosomal Abnormalities Screening, Rhesus Disease Screening), By Technology (Next Generation Sequencing, Microarray Analysis, Polymerase Chain Reaction) and By End Users (Hospitals, Diagnostic Laboratories, Direct-to-Consumer Companies) - Growth Outlook & Industry Forecast 2025 To 2035

GCC Non Invasive Prenatal Testing Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Test Type (USD Million)
  1. 4.1.1 Cell-Free Fetal DNA Testing
  2. 4.1.2 Biochemical Markers Testing
  3. 4.1.3 Ultrasound Screening
2. 4.2 Chemicals and Materials, BY Application (USD Million)
  1. 4.2.1 Trisomy Detection
  2. 4.2.2 Single Gene Disorders
  3. 4.2.3 Sex Chromosome Abnormalities
3. 4.3 Chemicals and Materials, BY Technology (USD Million)
  1. 4.3.1 Next-Generation Sequencing
  2. 4.3.2 Microarray Analysis
  3. 4.3.3 Massively Parallel Sequencing
4. 4.4 Chemicals and Materials, BY End User (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Diagnostic Laboratories
  3. 4.4.3 Research Institutions
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Illumina (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Natera (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Fulgent Genetics (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 LabCorp (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Quest Diagnostics (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 HaploX (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Genomic Health (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 GCC MARKET ANALYSIS BY TEST TYPE
3. 6.3 GCC MARKET ANALYSIS BY APPLICATION
4. 6.4 GCC MARKET ANALYSIS BY TECHNOLOGY
5. 6.5 GCC MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
12. 6.12 CHEMICALS AND MATERIALS, BY TEST TYPE, 2024 (% SHARE)
13. 6.13 CHEMICALS AND MATERIALS, BY TEST TYPE, 2024 TO 2035 (USD Million)
14. 6.14 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
15. 6.15 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
16. 6.16 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 (% SHARE)
17. 6.17 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
18. 6.18 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
19. 6.19 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 GCC MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TEST TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY TECHNOLOGY, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

GCC Chemicals and Materials Market Segmentation

Chemicals and Materials By Test Type (USD Million, 2025-2035)

Cell-Free Fetal DNA Testing
Biochemical Markers Testing
Ultrasound Screening

Chemicals and Materials By Application (USD Million, 2025-2035)

Trisomy Detection
Single Gene Disorders
Sex Chromosome Abnormalities

Chemicals and Materials By Technology (USD Million, 2025-2035)

Next-Generation Sequencing
Microarray Analysis
Massively Parallel Sequencing

Chemicals and Materials By End User (USD Million, 2025-2035)

Hospitals
Diagnostic Laboratories
Research Institutions

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”